-

Rite Aid Announces Availability of Opill at All Locations

The first FDA-approved over-the-counter daily birth control pill in the U.S. is now on shelves, available for purchase

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores. Opill is a progestin-only, daily oral contraceptive (birth control pill) that’s safe and effective when used as directed to help prevent pregnancy.

Opill over-the-counter birth control pills are available at Rite Aid for the suggested retail price of $19.99 for a one-month supply and $49.99 for a three-month supply. Both options are available for purchase at Rite Aid stores nationwide and online at RiteAid.com.

“Carrying an over-the-counter FDA-approved birth control pill is an important step in increasing access to reproductive health products and services for women,” said Karen Staniforth, Senior Vice President, Chief Pharmacy Officer at Rite Aid. “Rite Aid remains committed to providing convenient access to customers for all of their health and wellness needs.”

There are no restrictions for purchasing Opill. Rite Aid pharmacists are available to answer any customer questions about Opill.

About Rite Aid Corporation

Rite Aid is a full-service pharmacy committed to improving health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of solutions that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiary Bartell Drugs. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs nearly 6,000 pharmacists and operates more than 1,700 retail pharmacy locations across 16 states. For more information, visit www.riteaid.com.

Contacts

Catherine Carter
Rite Aid
717-975-5718
press@riteaid.com

Rite Aid Corporation

OTCBB:RADCQ
Details
Headquarters: Philadelphia, PA
CEO: Matt Schroeder
Employees: null
Organization: PRI

Release Versions

Contacts

Catherine Carter
Rite Aid
717-975-5718
press@riteaid.com

More News From Rite Aid Corporation

Rite Aid Shares ‘ABCs’ of Allergy Season to Help Nip Symptoms in the Bud

PHILADELPHIA--(BUSINESS WIRE)--Millions of Americans greet spring’s arrival with itchy eyes, runny noses and sneezing fits. Rite Aid is here to help customers manage those persistent allergy symptoms with simple solutions for the whole family before peak season arrives. “At Rite Aid, we understand how spring allergies can disrupt daily life and dampen outdoor plans. Our knowledgeable pharmacists are available to help customers find the best solutions to help manage their allergy symptoms,” said...

Rite Aid Responds to California Wildfires, Providing Support to Customers, Associates and Affected Communities

PHILADELPHIA--(BUSINESS WIRE)--At Rite Aid, the health and safety of our customers and associates is our top priority. In response to the ongoing wildfires in Los Angeles, we remain committed to supporting the community and ensuring access to essential medications and clinical services. During this declared emergency, pharmacists, located within the affected and surrounding counties, are able to provide emergency refills of certain prescriptions to customers impacted by the fires. Rite Aid’s st...

New Survey from Rite Aid Reveals Gaps in Consumer Awareness and Utilization of Pharmacist Expertise

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid today released the results of a new survey* to better understand the ways in which consumers engage with their pharmacists, and uncover additional ways pharmacists can support their overall health. “As industry research shows, many consumers visit their pharmacist far more frequently than their healthcare provider as patient appointments can take weeks to secure,” said Karen Staniforth, Chief Pharmacy Officer at Rite Aid. “Over the years, I’ve seen firsth...
Back to Newsroom